Kovitz Investment Group Partners
WST icon

Kovitz Investment Group Partners’s West Pharmaceutical WST Stock Holding History

Kovitz Investment Group Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,875
Closed -$754K – 1345
2025
Q3 		$754K Buy
2,875
+1,036
+56% +$252K ﹤0.01% 901
2025
Q2 		$402K Buy
1,839
+839
+84% +$179K ﹤0.01% 1052
2025
Q1 		$224K Buy
1,000
+93
+10% +$25.6K ﹤0.01% 1147
2024
Q4 		$297K Buy
+907
New +$285K ﹤0.01% 1047

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kovitz Investment Group Partners's WST Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 2,875 shares — an estimated $754K sold.

Kovitz Investment Group Partners first reported a position in WST in Q4 2024 and held it in 4 quarters. The position peaked at $754K in Q3 2025. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 2,875 West Pharmaceutical shares in Q4 2025, an estimated $754K.
  • Kovitz Investment Group Partners first reported a position in West Pharmaceutical in Q4 2024 and held it in 4 quarters.
  • Kovitz Investment Group Partners's West Pharmaceutical position peaked at $754K in Q3 2025.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.